Cibenzoline induced Brugada ECG pattern.

[1]  Y. Okumura,et al.  Wolff‐Parkinson‐White Syndrome Concomitant with Asymptomatic Brugada Syndrome , 2004, Pacing and clinical electrophysiology : PACE.

[2]  R. Hauer,et al.  Proposed diagnostic criteria for the Brugada syndrome. , 2002, European heart journal.

[3]  K. Shimamoto,et al.  Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population , 2001, Heart.

[4]  W. Shimizu,et al.  ST Segment and T Wave Alternans in a Patient with Brugada Syndrome , 2000, Pacing and clinical electrophysiology : PACE.

[5]  J. Towbin,et al.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.

[6]  P. Touboul,et al.  Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia. Cibenzoline and spontaneous VT. , 1998, International journal of cardiology.

[7]  H. Okayama,et al.  Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy. , 1997, Circulation.

[8]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[9]  G. Schmidt,et al.  Cibenzoline Review of its Pharmacological Properties and Therapeutic Potential in Arrhythmias , 1992 .